Compare Vir Biotechnology Inc. Common Stock (VIR) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs Vanguard International High Dividend Yield ETF — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.49 (market cap $1.76B), while Vanguard International High Dividend Yield ETF trades at $101.23 (market cap $22.80B). The key difference: Vanguard International High Dividend Yield ETF is far larger — about 13× Vir Biotechnology Inc. Common Stock's market cap, and Vanguard International High Dividend Yield ETF is more actively traded (718,572 versus 2,764,948). Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Vanguard International High Dividend Yield ETF for 51 Days on average.
| VIR | VYMI | |
|---|---|---|
Market Cap | $1.76B | $22.80B |
Volume | 2,764,948 | 718,572 |
Sector | Health | Broad Market / Factor |
52-Week High | $11.78 | $107.13 |
52-Week Low | $5.12 | $84.45 |
Typical Hold Time | 0 Days | 51 Days |
Enterprise Value | $1.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VYMI trades at $101.52, up 0.71% with a bearish technical signal from moving averages. The ETF shows strong institutional interest with recent stake increases by Envestnet and Corient Private Wealth. Recent news highlights VYMI's 29% one-year return and 3.61% dividend yield, outperforming peers with lower fees. The fund's heavy financial sector exposure (43.6%) benefits from rising global interest rates.
VYMI presents a compelling international dividend growth opportunity with attractive valuation and yield advantages over US counterparts. Key risks include currency fluctuations and global economic sensitivity. Analyst sentiment remains positive given the fund's consistent outperformance and institutional accumulation trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About Vanguard International High Dividend Yield ETF
VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →
